Shree Hari Chemicals Export Share Price
Sector: Chemical Manufacturing
149.90 -3.15 (-2.06%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
134.00
Today’s High
150.55
52 Week Low
65.65
52 Week High
173.90
Key Metrics
- Market Cap (In Cr) 64.56
- Beta 1.92
- Div. Yield (%) 0
- P/B 3.24
- TTM P/E 11.57
- Sector P/E 17.2
- Open Price 138
- Prev Close 153.05
Shree Hari Chemicals Export Analysis
Price Analysis
-
1 Week-5.5%
-
3 Months8.04%
-
6 Month33.17%
-
YTD5.95%
-
1 Year110.39%
Risk Meter
- 49% Low risk
- 49% Moderate risk
- 49% Balanced Risk
- 49% High risk
- 49% Extreme risk
Shree Hari Chemicals Export Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 137.65
- Selling/ General/ Admin Expenses Total
- 13.66
- Depreciation/ Amortization
- 2.28
- Other Operating Expenses Total
- 35.39
- Total Operating Expense
- 136.8
- Operating Income
- 0.85
- Net Income Before Taxes
- 3.22
- Net Income
- 2.29
- Diluted Normalized EPS
- 5.06
- Period
- 2024
- Total Assets
- 71.55
- Total Liabilities
- 51.26
- Total Equity
- 20.29
- Tangible Book Valueper Share Common Eq
- 45.63
- Period
- 2024
- Cashfrom Operating Activities
- 9.96
- Cashfrom Investing Activities
- -1.47
- Cashfrom Financing Activities
- -5.31
- Net Changein Cash
- 3.17
- Period
- 2023
- Total Revenue
- 102.58
- Selling/ General/ Admin Expenses Total
- 12.15
- Depreciation/ Amortization
- 2.12
- Other Operating Expenses Total
- 28.06
- Total Operating Expense
- 128.13
- Operating Income
- -25.55
- Net Income Before Taxes
- -26.45
- Net Income
- -19.8
- Diluted Normalized EPS
- -44.54
- Period
- 2023
- Total Assets
- 89.53
- Total Liabilities
- 71.59
- Total Equity
- 17.95
- Tangible Book Valueper Share Common Eq
- 40.36
- Period
- 2023
- Cashfrom Operating Activities
- -3.86
- Cashfrom Investing Activities
- -1.68
- Cashfrom Financing Activities
- 5.56
- Net Changein Cash
- 0.02
- Period
- 2022
- Total Revenue
- 76.45
- Selling/ General/ Admin Expenses Total
- 11.15
- Depreciation/ Amortization
- 1.41
- Other Operating Expenses Total
- 23.96
- Total Operating Expense
- 78.55
- Operating Income
- -2.1
- Net Income Before Taxes
- 1.06
- Net Income
- 0.68
- Diluted Normalized EPS
- 2.86
- Period
- 2022
- Total Assets
- 93.36
- Total Liabilities
- 55.81
- Total Equity
- 37.55
- Tangible Book Valueper Share Common Eq
- 84.46
- Period
- 2022
- Cashfrom Operating Activities
- 0
- Cashfrom Investing Activities
- 0
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0
- Period
- 2021
- Total Revenue
- 56.16
- Selling/ General/ Admin Expenses Total
- 9.48
- Depreciation/ Amortization
- 1.6
- Other Operating Expenses Total
- 14.3
- Total Operating Expense
- 55.68
- Operating Income
- 0.48
- Net Income Before Taxes
- 1.23
- Net Income
- 0.84
- Diluted Normalized EPS
- 1.9
- Period
- 2021
- Total Assets
- 59.62
- Total Liabilities
- 22.76
- Total Equity
- 36.85
- Tangible Book Valueper Share Common Eq
- 82.89
- Period
- 2021
- Cashfrom Operating Activities
- -1.01
- Cashfrom Investing Activities
- -0.21
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -1.22
- Period
- 2020
- Total Revenue
- 57.1
- Selling/ General/ Admin Expenses Total
- 9.37
- Depreciation/ Amortization
- 2.15
- Other Operating Expenses Total
- 17.22
- Total Operating Expense
- 59.83
- Operating Income
- -2.73
- Net Income Before Taxes
- -1.93
- Net Income
- -1.6
- Diluted Normalized EPS
- -3.61
- Period
- 2020
- Total Assets
- 56.79
- Total Liabilities
- 20.8
- Total Equity
- 36
- Tangible Book Valueper Share Common Eq
- 80.96
- Period
- 2020
- Cashfrom Operating Activities
- 0.08
- Cashfrom Investing Activities
- 0.88
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 0.97
- Period
- 2019
- Total Revenue
- 50.52
- Selling/ General/ Admin Expenses Total
- 9.3
- Depreciation/ Amortization
- 2.87
- Other Operating Expenses Total
- 14.71
- Total Operating Expense
- 56.13
- Operating Income
- -5.61
- Net Income Before Taxes
- -4.21
- Net Income
- -3.57
- Diluted Normalized EPS
- -8.03
- Period
- 2019
- Total Assets
- 45.87
- Total Liabilities
- 8.22
- Total Equity
- 37.65
- Tangible Book Valueper Share Common Eq
- 84.67
- Period
- 2019
- Cashfrom Operating Activities
- -5.44
- Cashfrom Investing Activities
- 1.49
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -3.95
- Period
- 2024-12-31
- Total Revenue
- 39.02
- Selling/ General/ Admin Expenses Total
- 3.74
- Depreciation/ Amortization
- 0.54
- Other Operating Expenses Total
- 9.34
- Total Operating Expense
- 35.13
- Operating Income
- 3.88
- Net Income Before Taxes
- 3.52
- Net Income
- 2.63
- Diluted Normalized EPS
- 4.17
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 36.28
- Selling/ General/ Admin Expenses Total
- 3.7
- Depreciation/ Amortization
- 0.5
- Other Operating Expenses Total
- 8.28
- Total Operating Expense
- 32.94
- Operating Income
- 3.34
- Net Income Before Taxes
- 3.07
- Net Income
- 2.24
- Diluted Normalized EPS
- 5.05
- Period
- 2024-09-30
- Total Assets
- 75.29
- Total Liabilities
- 52.54
- Total Equity
- 22.74
- Tangible Book Valueper Share Common Eq
- 51.15
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 2.76
- Cashfrom Investing Activities
- -0.95
- Cashfrom Financing Activities
- -2.23
- Net Changein Cash
- -0.42
- Period
- 2024-06-30
- Total Revenue
- 30.87
- Selling/ General/ Admin Expenses Total
- 3.68
- Depreciation/ Amortization
- 0.5
- Other Operating Expenses Total
- 8.41
- Total Operating Expense
- 30.11
- Operating Income
- 0.77
- Net Income Before Taxes
- 0.28
- Net Income
- 0.21
- Diluted Normalized EPS
- 0.47
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 32.23
- Selling/ General/ Admin Expenses Total
- 3.53
- Depreciation/ Amortization
- 0.58
- Other Operating Expenses Total
- 9.67
- Total Operating Expense
- 35.33
- Operating Income
- -3.1
- Net Income Before Taxes
- 0.45
- Net Income
- 0.28
- Diluted Normalized EPS
- 5.69
- Period
- 2024-03-31
- Total Assets
- 71.55
- Total Liabilities
- 51.26
- Total Equity
- 20.29
- Tangible Book Valueper Share Common Eq
- 45.63
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 9.96
- Cashfrom Investing Activities
- -1.47
- Cashfrom Financing Activities
- -5.31
- Net Changein Cash
- 3.17
- Period
- 2023-12-31
- Total Revenue
- 36.98
- Selling/ General/ Admin Expenses Total
- 3.62
- Depreciation/ Amortization
- 0.57
- Other Operating Expenses Total
- 9.48
- Total Operating Expense
- 35.26
- Operating Income
- 1.72
- Net Income Before Taxes
- 1.39
- Net Income
- 1.04
- Diluted Normalized EPS
- 2.33
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Shree Hari Chemicals Export Technical
Moving Average
SMA
- 5 Day152.52
- 10 Day154.61
- 20 Day152.88
- 50 Day151
- 100 Day145.38
- 300 Day125.87
Shree Hari Chemicals Export Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Mysore Petro Chemicals
- 127.05
- -1.4
- -1.09
- 261.9
- 117.45
- 83.12
- Kemistar Corporation
- 74.26
- -4.74
- -6
- 116.45
- 37
- 79.9
- Shree Hari Chemicals Export
- 149.9
- -3.15
- -2.06
- 173.9
- 65.65
- 64.56
- Eiko Lifesciences
- 51.5
- -1.04
- -1.98
- 74.88
- 42
- 64.1
- Aeonx Digital Technology
- 148.2
- -7.75
- -4.97
- 323.3
- 98.65
- 68.55
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Mysore Petro Chemicals
- -
- -
- -
- -
- Kemistar Corporation
- 150.44
- 4.45
- 3.75
- 3.93
- Shree Hari Chemicals Export
- 29.23
- 3.24
- -11.18
- -4.09
- Eiko Lifesciences
- 35.53
- 1.24
- 3.39
- 4.25
- Aeonx Digital Technology
- 35.4
- 1.43
- 1.14
- 1.12
Shree Hari Chemicals Export Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results & Final Dividend
- 12-Feb-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results
- 27-May-24
- Audited Results & Final Dividend
- 14-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 14-Aug-23
- Quarterly Results
- 25-May-23
- Audited Results & Final Dividend
- 14-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 06-Jun-25
- 05-May-25
- POM
- 27-Sept-24
- 28-Aug-24
- AGM
- 27-Sept-23
- 14-Aug-23
- AGM
- 28-Sept-22
- 27-May-22
- AGM
- 17-Sept-21
- 12-Jul-21
- AGM
- 19-Mar-21
- 23-Feb-21
- EGM
- 30-Dec-20
- 11-Nov-20
- AGM



